|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Share based compensation expenses to employees and non-employees | |||||
| Capital Gain | |||||
| Capital loss (Gain) | |||||
| Financial expenses related to convertible loans, warrants and leases | |||||
| Change in fair value of convertible component in convertible loans | |||||
| Changes in assets and liabilities: | |||||
| Decrease (increase) in other accounts receivables | |||||
| Decrease (Increase) in other accounts receivable | |||||
| Increase in accounts receivable | |||||
| Decrease (Increase) in trade payables | |||||
| Decrease (Increase) in other accounts payables | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Decrease (increase) in restricted cash | |||||
| Purchase of property and equipment | |||||
| Decrease in deposits | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Lease payments | |||||
| Proceeds from convertible loan | |||||
| Proceeds from issuance of shares of subsidiary | |||||
| Repayment of convertible loans | |||||
| Loans from related parties | |||||
| Net cash provided by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents and restricted cash at the beginning of the year | |||||
| Cash and cash equivalents at the end of the period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
Loading...
